{
  "retracted": false,
  "timestamp": 1467849600000,
  "updates": [
    {
      "timestamp": 1495725376074,
      "identifier": {
        "doi": "10.1038/srep28124"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/srep26428"
  },
  "journal": "Scientific Reports",
  "publisher": "Springer Nature",
  "title": "Erratum: Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice"
}
